Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-003623

Options or other derivatives

  • Director acquired 89,501 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MATLIN DAVID J Director 2025-02-10 Other acquisition · Series A Preferred Stock +89,501 189,501 D
Loading xslF345X05/form4-02112025_110217.xml…